JC virus antibody

From Aaushi
Jump to navigation Jump to search

Indications

Clinical significance

Methods

ELISA

More general terms

Additional terms

References

  1. FDA NEWS RELEASE: January 20, 2012 FDA permits marketing of first test for risk of rare brain infection in some people treated with Tysabri http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm288471.htm